Clinical Trial Update: NOPE37: Angiogenic Factors for Managing Term Preeclampsia [NA]

View source ↗

Summary

NOPE37 is a clinical trial investigating angiogenic factors for managing term preeclampsia. The study is currently recruiting at Hospital Universitari Vall d'He…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Preeclampsia

Snippet

Sponsor: Hospital Universitari Vall d'Hebron Research Institute | Conditions: Preeclampsia | NA | Status: RECRUITING